Vesicant treatment with phenyl-thiophene type vitamin d receptor modulators
申请人:Nagpal Sunil
公开号:US20060135484A1
公开(公告)日:2006-06-22
The present invention relates to a method of treating or preventing damage to human skin cells by chemical vesicants by administering a non-secosteroidal, phenylthiophene compound with vitamin D receptor (VDR) modulating activity.
Phenyl-thiophene type vitamin D receptor modulators
申请人:Eli Lilly & Company
公开号:EP2184281A1
公开(公告)日:2010-05-12
The present invention relates to novel, non-secosteroidal, phenyl-thiophene compounds with vitamin D receptor (VDR) modulating activity that are less hypercalcemic than 1α,25 dihydroxy vitamin D3. These compounds are useful for treating bone disease and psoriasis.
本发明涉及具有维生素 D 受体(VDR)调节活性的新型非甾体苯基噻吩化合物,其高钙血症性低于 1α,25 二羟基维生素 D3。这些化合物可用于治疗骨病和牛皮癣。
PHENYL-THIOPHENE TYPE VITAMIN D RECEPTOR MODULATORS